ComBioMed platform for drug discovery

The Sotelo laboratory has a long and successful track record in collaborative research programs with biotechnological companies. We enjoy working closely with our partners and during these years we have built a robust reputation and demonstrated a commitment to pursuing customer goals and meeting expectations. The strong medicinal and synthetic background developed by the group during the last 15 years is now available for industrial-based collaborative projects.



The ComBioMed platform is an initiative providing our customers and research partners access to our in-house multicomponent-based platform for drug discovery, research contracts to develop new chemistry that is able to accelerate hit discovery and hit-to-lead or lead optimization programs. Moreover, we offer access to the ComBioMed screening library, a collection of nearly 7000 highly diverse heterocyclic compounds assembled using MCR chemistry.